Daewoong Pharma disclosed Wednesday that its second-quarter operating profit on a separate basis rose 23.4% from a year earlier to 77.11 billion won ($52.6 million).
Revenue for the same period grew 10% to 400.19 billion won.
Net profit for the period came to 69.4 billion won, up 41.9%, on a preliminary basis.
jiyoon436@heraldcorp.com
